Eur Rev Med Pharmacol Sci 2018; 22 (3): 575-577

DOI: 10.26355/eurrev_201802_14265

Evaluation of genotyping methods and costs for IL1α polymorphisms in Platelet Rich-Plasma (PRP); viewpoint for therapy on the diabetic foot ulcers

G. Marotta, A. Licito, E. Serra, G. Benincasa, A. Crisci

ISCD Institute for Studies and Care on Diabetics, Abretaia, Casagiove, Caserta, Italy. infodue@diabetologia.it

Free PDF Download

To cite this article

G. Marotta, A. Licito, E. Serra, G. Benincasa, A. Crisci
Evaluation of genotyping methods and costs for IL1α polymorphisms in Platelet Rich-Plasma (PRP); viewpoint for therapy on the diabetic foot ulcers

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 3
Pages: 575-577
DOI: 10.26355/eurrev_201802_14265

Keywords Related articles:

  1. Evaluation of genotyping methods and costs for VDR polymorphisms
  2. Chronic anti-platelet therapy: a contraindication for platelet-rich plasma intra-articular injections?
  3. Evaluation of genotyping methods and the relative cost of pharmacogenomics
  4. Effects of platelet-rich plasma on angiogenesis and osteogenesis-associated factors in rabbits with avascular necrosis of the femoral head
  5. Correlation between individual inflammation genetic profile and platelet rich plasma efficacy in hair follicle regeneration: a pilot study reveals prognostic value of IL-1a polymorphism